Showing results (1021-1030 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|April 7, 2025
Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk-Benefit AnalysisUtkarsh Chauhan, Daylen Mackey, John R MackeyPharmaceutical Statistics|May 6, 2025
Applying the Principal Stratum Strategy in Equivalence Trials: A Case StudyJerome Sepin, Thomas P A Debray, Wei Wei, et al.Pharmaceutical Statistics|November 17, 2025
Statistical Consideration for Event-Free Survival With Cure Rate in Acute Myeloid Leukemia StudiesYuichiro Kaneko, Kentaro Takeda, Shufang Liu, et al.Pharmaceutical Statistics|November 7, 2025
Order of Addition in Mixture-Amount ExperimentsTaha Hasan, Touqeer AhmadPharmaceutical Statistics|August 12, 2025
The Wilcoxon-Mann-Whitney Estimand Versus Differences in Medians or MeansLinda J Harrison, Ronald J BoschPharmaceutical Statistics|September 11, 2025
Finding the Optimal Number of Splits and Repetitions in Double Cross-Fitting Targeted Maximum Likelihood EstimatorsMohammad Ehsanul Karim, Momenul Haque MondolPharmaceutical Statistics|July 29, 2025
Mediation Analysis of Path-Specific Effects in Randomised Clinical Trials With Repeatedly Measured Mediators and OutcomesMartin Linder, Jesper Madsen, Stijn VansteelandtPharmaceutical Statistics|March 27, 2025
A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data AssumptionsCesar Torres, Gregory Levin, Daniel Rubin, et al.Pharmaceutical Statistics|March 27, 2025
Randomization in Pre-Clinical Studies: When Evolution Theory Meets StatisticsSofia Weigle, Davit Sargsyan, Javier Cabrera, et al.Pharmaceutical Statistics|September 17, 2013
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysisDavid Ohlssen, Karen L Price, H Amy Xia, et al.Pageof 120